Q fever vaccine development: Challenges and progress in balancing safety and efficacy

The existing human vaccine against Q fever, a zoonotic disease of biothreat concern, is approved only in Australia. In this issue of Cell Reports Medicine, Gregory and colleagues describe a new vaccine candidate that overcomes specific concerns hindering wider acceptance of the commercial vaccine.(1...

Descripción completa

Detalles Bibliográficos
Autores principales: Sluder, Ann E., Poznansky, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715067/
https://www.ncbi.nlm.nih.gov/pubmed/35028619
http://dx.doi.org/10.1016/j.xcrm.2021.100480
_version_ 1784624059347107840
author Sluder, Ann E.
Poznansky, Mark C.
author_facet Sluder, Ann E.
Poznansky, Mark C.
author_sort Sluder, Ann E.
collection PubMed
description The existing human vaccine against Q fever, a zoonotic disease of biothreat concern, is approved only in Australia. In this issue of Cell Reports Medicine, Gregory and colleagues describe a new vaccine candidate that overcomes specific concerns hindering wider acceptance of the commercial vaccine.(1)
format Online
Article
Text
id pubmed-8715067
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87150672022-01-12 Q fever vaccine development: Challenges and progress in balancing safety and efficacy Sluder, Ann E. Poznansky, Mark C. Cell Rep Med Preview The existing human vaccine against Q fever, a zoonotic disease of biothreat concern, is approved only in Australia. In this issue of Cell Reports Medicine, Gregory and colleagues describe a new vaccine candidate that overcomes specific concerns hindering wider acceptance of the commercial vaccine.(1) Elsevier 2021-12-21 /pmc/articles/PMC8715067/ /pubmed/35028619 http://dx.doi.org/10.1016/j.xcrm.2021.100480 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Preview
Sluder, Ann E.
Poznansky, Mark C.
Q fever vaccine development: Challenges and progress in balancing safety and efficacy
title Q fever vaccine development: Challenges and progress in balancing safety and efficacy
title_full Q fever vaccine development: Challenges and progress in balancing safety and efficacy
title_fullStr Q fever vaccine development: Challenges and progress in balancing safety and efficacy
title_full_unstemmed Q fever vaccine development: Challenges and progress in balancing safety and efficacy
title_short Q fever vaccine development: Challenges and progress in balancing safety and efficacy
title_sort q fever vaccine development: challenges and progress in balancing safety and efficacy
topic Preview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715067/
https://www.ncbi.nlm.nih.gov/pubmed/35028619
http://dx.doi.org/10.1016/j.xcrm.2021.100480
work_keys_str_mv AT sluderanne qfevervaccinedevelopmentchallengesandprogressinbalancingsafetyandefficacy
AT poznanskymarkc qfevervaccinedevelopmentchallengesandprogressinbalancingsafetyandefficacy

Ejemplares similares